Generation of Human Lak Cells in Tissue Culture Bags Using Recombinant Il-2 and Serum Free Medium Effects of pretreatment with phenylalanine-methylester

Authors

  • P. Wersäll Department of Oncology, Radiumhemmet, Immunologic Research Laboratory, Stockholm, Sweden; Department of Transfusion Medicine, Karolinska Hospital, Stockholm, Sweden; Departments of Toxicology, Medical Radiobiology, and Immunology, Karolinska Institute, Stockholm, Sweden
  • G. Masucci Department of Oncology, Radiumhemmet, Immunologic Research Laboratory, Stockholm, Sweden; Department of Transfusion Medicine, Karolinska Hospital, Stockholm, Sweden; Departments of Toxicology, Medical Radiobiology, and Immunology, Karolinska Institute, Stockholm, Sweden
  • P. Pihlstedt Department of Oncology, Radiumhemmet, Immunologic Research Laboratory, Stockholm, Sweden; Department of Transfusion Medicine, Karolinska Hospital, Stockholm, Sweden; Departments of Toxicology, Medical Radiobiology, and Immunology, Karolinska Institute, Stockholm, Sweden
  • I. Cotgreave Department of Oncology, Radiumhemmet, Immunologic Research Laboratory, Stockholm, Sweden; Department of Transfusion Medicine, Karolinska Hospital, Stockholm, Sweden; Departments of Toxicology, Medical Radiobiology, and Immunology, Karolinska Institute, Stockholm, Sweden
  • B. Tribukait Department of Oncology, Radiumhemmet, Immunologic Research Laboratory, Stockholm, Sweden; Department of Transfusion Medicine, Karolinska Hospital, Stockholm, Sweden; Departments of Toxicology, Medical Radiobiology, and Immunology, Karolinska Institute, Stockholm, Sweden
  • M. Ullberg Department of Oncology, Radiumhemmet, Immunologic Research Laboratory, Stockholm, Sweden; Department of Transfusion Medicine, Karolinska Hospital, Stockholm, Sweden; Departments of Toxicology, Medical Radiobiology, and Immunology, Karolinska Institute, Stockholm, Sweden
  • H. Wigzell Department of Oncology, Radiumhemmet, Immunologic Research Laboratory, Stockholm, Sweden; Department of Transfusion Medicine, Karolinska Hospital, Stockholm, Sweden; Departments of Toxicology, Medical Radiobiology, and Immunology, Karolinska Institute, Stockholm, Sweden
  • H. Mellstedt Department of Oncology, Radiumhemmet, Immunologic Research Laboratory, Stockholm, Sweden; Department of Transfusion Medicine, Karolinska Hospital, Stockholm, Sweden; Departments of Toxicology, Medical Radiobiology, and Immunology, Karolinska Institute, Stockholm, Sweden

DOI:

https://doi.org/10.3109/02841869009090026

Keywords:

LAK cells, IL-2, monocytes, phenylalanine-methylester

Abstract

A technique for processing and culturing of human LAK cells using an automated closed system and tissue culture bags is described. To circumvent the inhibitory effects of monocytes on LAK cells the peripheral blood mononuclear cells (PBMC) were pretreated with phenylalanine-methylester (PheOMe). PBMC were obtained from healthy donors by leukapheresis of whole blood. After pretreatment with PheOMe and culturing with IL-2 for 96 h, 60% of the cells remained. PheOMe significantly reduced the number of monocytes (Leu-M3+ cells) from 20–12%. The lytic activity (against K562 and Daudi) of non-PheOMe-treated cells reached a plateau at 72–96 h while PheOMe-treated cells reached maximum activity at 96 h. The total lytic activity/tissue culture bag at 96 h of PheOMe-pretreated cells was significantly augmented in comparison to non-PheOMe-pretreated cells. The present technique allows rapid and simple generation of LAK cells without serum in sterile receptacles suitable for therapy. Additionally, the LAK cell efficacy was improved by reducing the inhibitory effects of monocytes.

Downloads

Download data is not yet available.

Downloads

Published

1989-05-31

How to Cite

Wersäll, P., Masucci, G., Pihlstedt, P., Cotgreave, I., Tribukait, B., Ullberg, M., … Mellstedt, H. (1989). Generation of Human Lak Cells in Tissue Culture Bags Using Recombinant Il-2 and Serum Free Medium Effects of pretreatment with phenylalanine-methylester. Acta Oncologica, 29(4), 431–437. https://doi.org/10.3109/02841869009090026

Issue

Vol. 29 No. 4 (1990): Acta Oncologica

Section

Articles